SCHEMBL6428150

SCHEMBL6428150

CN(C(=O)CC1SC(NC23CC4CC(CC(C4)C2)C3)=NC1=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
GAA P10253 2/20 0.37
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FAAH O00519 2/20 0.35
EPHX2 P34913 4/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
CNR2 P34972 2/20 0.34
CNR1 P21554 2/20 0.34
MAPT P10636 1/20 0.34
G6PD P11413 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428317 0.81 PKM (0.40) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL6427221 0.79 MAPT (0.38) ALDH1A1GAAL3MBTL1KDM4EMEN1
SCHEMBL6425910 0.79 PKM (0.46) ALDH1A1GAALMNAL3MBTL1MEN1
SCHEMBL6426785 0.78 MAPT (0.38) ALDH1A1GAAKDM4EMEN1HTT
SCHEMBL6428237 0.78 PKM (0.48) ALDH1A1LMNAEPHX2KDM4EMEN1
SCHEMBL6426356 0.78 PKM (0.48) ALDH1A1LMNAEPHX2KDM4EMEN1
SCHEMBL6427858 0.77 ALDH1A1 (0.36) ALDH1A1GAALMNAKDM4EMEN1
SCHEMBL6427691 0.76 ALDH1A1 (0.33) ALDH1A1GAALMNAEPHX2MEN1
SCHEMBL6393714 0.76 EPHX2 (0.44) ALDH1A1GAALMNAL3MBTL1EPHX2
SCHEMBL6427395 0.76 KMT2A (0.40) ALDH1A1GAALMNAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US claimed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO claimed
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US disclosed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239853-A1 New compounds HSD11B1, CYP11B1, HSD3B1 ALDH1A1 67/4885GAA 522/4885MAPK1 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.